ArticleJAMA network open2018

Availability of Investigational Medicines Through the US Food and Drug Administration's Expanded Access and Compassionate Use Programs.

Jeremy Puthumana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.